ATE149832T1 - Verwendung von cromakalim/brl 38227 zur behandlung der überreaktivität der luftwege - Google Patents
Verwendung von cromakalim/brl 38227 zur behandlung der überreaktivität der luftwegeInfo
- Publication number
- ATE149832T1 ATE149832T1 AT91900304T AT91900304T ATE149832T1 AT E149832 T1 ATE149832 T1 AT E149832T1 AT 91900304 T AT91900304 T AT 91900304T AT 91900304 T AT91900304 T AT 91900304T AT E149832 T1 ATE149832 T1 AT E149832T1
- Authority
- AT
- Austria
- Prior art keywords
- cromakalim
- brl
- overreactivity
- treat airway
- airway
- Prior art date
Links
- TVZCRIROJQEVOT-CABCVRRESA-N Cromakalim Chemical compound N1([C@@H]2C3=CC(=CC=C3OC([C@H]2O)(C)C)C#N)CCCC1=O TVZCRIROJQEVOT-CABCVRRESA-N 0.000 title abstract 4
- 229950004210 cromakalim Drugs 0.000 title abstract 2
- 241000124008 Mammalia Species 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 238000011321 prophylaxis Methods 0.000 abstract 2
- 238000011282 treatment Methods 0.000 abstract 2
- 230000035874 hyperreactivity Effects 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Steroid Compounds (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB898927980A GB8927980D0 (en) | 1989-12-11 | 1989-12-11 | Pharmaceuticals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE149832T1 true ATE149832T1 (de) | 1997-03-15 |
Family
ID=10667773
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT91900304T ATE149832T1 (de) | 1989-12-11 | 1990-12-11 | Verwendung von cromakalim/brl 38227 zur behandlung der überreaktivität der luftwege |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0471040B1 (de) |
| AT (1) | ATE149832T1 (de) |
| AU (1) | AU7994891A (de) |
| DE (1) | DE69030181T2 (de) |
| DK (1) | DK0471040T3 (de) |
| ES (1) | ES2100941T3 (de) |
| GB (1) | GB8927980D0 (de) |
| GR (1) | GR3023250T3 (de) |
| IE (1) | IE904460A1 (de) |
| WO (1) | WO1991008741A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9124754D0 (en) * | 1991-11-21 | 1992-01-15 | Smithkline Beecham Plc | Pharmaceuticals |
| US5646156A (en) * | 1994-04-25 | 1997-07-08 | Merck & Co., Inc. | Inhibition of eosinophil activation through A3 adenosine receptor antagonism |
| WO2015117024A1 (en) | 2014-01-31 | 2015-08-06 | Mayo Foundation For Medical Education And Research | Novel therapeutics for the treatment of glaucoma |
| AU2020403144A1 (en) | 2019-12-12 | 2022-07-14 | Mayo Foundation For Medical Education And Research | Controlled-delivery cromakalim prodrugs |
-
1989
- 1989-12-11 GB GB898927980A patent/GB8927980D0/en active Pending
-
1990
- 1990-12-10 IE IE446090A patent/IE904460A1/en unknown
- 1990-12-11 DE DE69030181T patent/DE69030181T2/de not_active Expired - Lifetime
- 1990-12-11 DK DK91900304.6T patent/DK0471040T3/da active
- 1990-12-11 AT AT91900304T patent/ATE149832T1/de not_active IP Right Cessation
- 1990-12-11 AU AU79948/91A patent/AU7994891A/en not_active Abandoned
- 1990-12-11 WO PCT/GB1990/001934 patent/WO1991008741A1/en not_active Ceased
- 1990-12-11 ES ES91900304T patent/ES2100941T3/es not_active Expired - Lifetime
- 1990-12-11 EP EP91900304A patent/EP0471040B1/de not_active Expired - Lifetime
-
1997
- 1997-04-22 GR GR970400915T patent/GR3023250T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2100941T3 (es) | 1997-07-01 |
| IE904460A1 (en) | 1991-06-19 |
| EP0471040B1 (de) | 1997-03-12 |
| DK0471040T3 (da) | 1997-04-01 |
| WO1991008741A1 (en) | 1991-06-27 |
| DE69030181T2 (de) | 1997-07-17 |
| GR3023250T3 (en) | 1997-07-30 |
| EP0471040A1 (de) | 1992-02-19 |
| GB8927980D0 (en) | 1990-02-14 |
| DE69030181D1 (de) | 1997-04-17 |
| AU7994891A (en) | 1991-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG100960A (bg) | Дозирани форми с контролирано освобождаване на азитромицин | |
| DE3878866D1 (de) | 3-indolpyruvsaeure-derivate und deren verwendung als arznemittel. | |
| DE69132823D1 (de) | Knochen- und knorpel-bildung hervorrufende proteine | |
| ATE233558T1 (de) | Verwendung von strontiumsälze zur behandlung von arthrose | |
| DE69027865D1 (de) | ZUSAMMENSETZUNGEN enthaltend omega Conotoxin Peptide Derivate und deren Verwendung ZUR BEHANDLUNG VON ISCHÄMIE-ARTIGEN NEURONALEN SCHÄDIGUNGEN | |
| DE3779149D1 (de) | Galanthamin oder dessen analoge zur behandlung der alzheimerschen krankheit. | |
| DE69528475D1 (de) | Verwendung von serotonin-antagonisten (5ht3) zur behandlung von fibromyalgie | |
| DE69532804D1 (de) | Verwendung von hemmern des maillard-reaktion zur behandlung von krankheiten zufolge amyloidosis | |
| DE69010162D1 (de) | Zusammensetzung zur Behandlung von Entzündung. | |
| ZA926837B (en) | A pharmaceutical composition for and a method of using a combination of an uricosuric agent and an EAA antagonist | |
| PT627221E (pt) | Substancias antagonistas p para o tratamento de emese | |
| CA2070685A1 (en) | Method for treating painful, inflammatory or allergic disorders | |
| KR890701099A (ko) | 기침 및 기관지 협착을 치료하기 위한 5-ht3 수용기 길항물질 | |
| HU891056D0 (en) | Process for treating the diseases of the gullet and the stomach-intestine system | |
| DE69030181D1 (de) | Verwendung von cromakalim/brl 38227 zur behandlung der überreaktivität der luftwege | |
| FI954245A7 (fi) | Koostumuksia ja menetelmiä immunovälitteisten tulehduksellisten häiriö iden hoitamiseksi | |
| DE69021257D1 (de) | Verwendung von IFN-gamma zur Herstellung einer pharmazeutischen Zusammensetzung für die Behandlung von ATL. | |
| NO984160D0 (no) | Fremgangsmåte for behandling eller forebyggelse av interstitiell cystitt | |
| ATE179594T1 (de) | Verwendung von ethisterone zur topischen behandlung von akne oder androgenetischer alopezie | |
| ATE234614T1 (de) | Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren | |
| DK0583281T3 (da) | Modgift - immunsera | |
| ATE287713T1 (de) | Verwendung von riluzol zur behandlung multipler sklerose | |
| DE69429013D1 (de) | Verwendung von dimeticon zur behandlung der konstipation | |
| UA39179C2 (uk) | Фармацевтична композиція для лікування порушень серцевого ритму у великих ссавців та людей, спосіб її одержання та антиаритмічний лікарський засіб | |
| ATE225181T1 (de) | Verwendung von heparinen niedrigeren molekulargewichtes zur behandlung von hirnödemen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| EELA | Cancelled due to lapse of time |